Drug Pipeline Progress: Positive clinical trial results for Hoth Therapeutics' drug candidates typically drive the stock price higher. Conversely, setbacks or failures in clinical trials can lead to a price decrease. Regulatory Approvals: FDA approvals for Hoth's products are major catalysts that significantly boost investor confidence and increase stock value. Delays or rejections can have a negative impact. Market Competition: The competitive landscape in the dermatology and immunology fields affects Hoth's potential market share and revenue. Stronger competitors or new entrants can put downward pressure on the stock. Financial Performance: Hoth's cash position, revenue generation (if any), and expenses influence investor sentiment. A strong financial position is generally viewed favorably, while concerns about funding can negatively affect the stock. Overall Market Conditions: Broad market trends, such as economic growth or recession, and sector-specific trends in the biotechnology industry can influence investor behavior and impact Hoth's stock price. News and Announcements: Company-specific news, such as partnerships, acquisitions, or new research findings, can create volatility in the stock price.